Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Reinisch

Showing results (121-130 of 352) with videos related to

Pageof 36
Sort By:
Journal of Crohn'S & Colitis|November 27, 2020
End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's DiseaseEmily C L Wong, Elisa Buffone, So Jeong Lee, et al.
Inflammatory Bowel Diseases|June 30, 2025
Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE TrialDhruv Ahuja, Sama Anvari, Emily C L Wong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2021
Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative ColitisNeeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
The American Journal of Gastroenterology|February 25, 2025
A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and PracticePeter W Huan, Akash Mehta, Emily C L Wong, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurinesAndrea Walch, Miena Meshkat, Harald Vogelsang, et al.
Inflammatory Bowel Diseases|June 13, 2020
Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's DiseaseSusanna Scharrer, Donata Lissner, Christian Primas, et al.
Digestive Diseases and Sciences|November 9, 2014
Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's diseaseHeimo H Wenzl, Christian Primas, Gottfried Novacek, et al.
United European Gastroenterology Journal|September 6, 2023
Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel diseasePauline Wils, Vipul Jairath, Bruce E Sands, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2018
Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitisRaja Atreya, Walter Reinisch, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases|August 20, 2010
Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseasesPavol Papay, Alexander Eser, Stefan Winkler, et al.
Pageof 36

Showing results (121-130 of 352) with videos related to

Sort By:
Pageof 36
Journal of Crohn'S & Colitis|November 27, 2020
End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's DiseaseEmily C L Wong, Elisa Buffone, So Jeong Lee, et al.
Inflammatory Bowel Diseases|June 30, 2025
Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE TrialDhruv Ahuja, Sama Anvari, Emily C L Wong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2021
Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative ColitisNeeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
The American Journal of Gastroenterology|February 25, 2025
A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and PracticePeter W Huan, Akash Mehta, Emily C L Wong, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurinesAndrea Walch, Miena Meshkat, Harald Vogelsang, et al.
Inflammatory Bowel Diseases|June 13, 2020
Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's DiseaseSusanna Scharrer, Donata Lissner, Christian Primas, et al.
Digestive Diseases and Sciences|November 9, 2014
Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's diseaseHeimo H Wenzl, Christian Primas, Gottfried Novacek, et al.
United European Gastroenterology Journal|September 6, 2023
Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel diseasePauline Wils, Vipul Jairath, Bruce E Sands, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2018
Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitisRaja Atreya, Walter Reinisch, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases|August 20, 2010
Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseasesPavol Papay, Alexander Eser, Stefan Winkler, et al.
Pageof 36